ZSCAN29 Knockout cell line (HEK293-A)

Ubigene gene knockout cell lines mediated by optimized CRISPR-Cas9 technology provide reliable in vitro models for investigating gene function, signaling pathways, disease mechanisms, and therapeutic targets.

ZSCAN29 (zinc finger and SCAN domain containing 29) encodes a zinc finger and SCAN domain-containing protein with sequence-specific double-stranded DNA-binding activity. ZSCAN29 is predicted to function in regulation of RNA polymerase II-dependent transcription and to localize to the nucleus. Through its DNA-binding and transcriptional regulatory properties, ZSCAN29 may contribute to control of gene expression, although its specific transcriptional targets and biological roles remain incompletely characterized.

Comprehensive quality control includes STR authentication, sterility testing (bacteria and fungi), and mycoplasma screening to ensure purity and performance. Genotype is confirmed by two rounds of PCR and Sanger sequencing, and complete validation reports are provided for make-to-order products.